Jim Simons Standard Biotools Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Standard Biotools Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 201,000 shares of LAB stock, worth $321,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares

201,000

Previous 1,004,558 79.99%

Holding current value

$321,600

Previous $1.78 Million 78.23%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.42 - $2.35 $1.14 Million - $1.89 Million	-803,558 Reduced 79.99%	201,000 $387,000
Q2 2024 Aug 09, 2024	SELL	$1.65 - $2.92 $411,345 - $727,956	-249,300 Reduced 19.88%	1,004,558 $1.78 Million
Q1 2024 May 13, 2024	BUY	$1.87 - $2.78 $400,662 - $595,637	214,258 Added 20.61%	1,253,858 $3.4 Million
Q4 2023 Feb 13, 2024	BUY	$1.59 - $2.73 $677,658 - $1.16 Million	426,200 Added 69.48%	1,039,600 $2.3 Million
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.05 $22,627 - $36,322	-11,909 Reduced 1.9%	613,400 $1.78 Million
Q2 2023 Aug 11, 2023	BUY	$1.47 - $2.56 $424,843 - $739,863	289,009 Added 85.94%	625,309 $1.21 Million
Q1 2023 May 12, 2023	BUY	$1.3 - $2.24 $47,060 - $81,088	36,200 Added 12.06%	336,300 $656,000
Q4 2022 Feb 13, 2023	SELL	$0.93 - $1.52 $40,920 - $66,880	-44,000 Reduced 12.79%	300,100 $351,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $2.06 $123,420 - $231,132	112,200 Added 48.38%	344,100 $379,000
Q2 2022 Aug 12, 2022	BUY	$1.6 - $3.99 $183,040 - $456,456	114,400 Added 97.36%	231,900 $371,000
Q1 2022 May 13, 2022	BUY	$2.8 - $3.96 $280,000 - $396,000	100,000 Added 571.43%	117,500 $422,000
Q4 2021 Feb 11, 2022	BUY	$3.63 - $6.13 $63,525 - $107,275	17,500 New	17,500 $69,000
Q1 2021 May 13, 2021	SELL	$3.94 - $7.09 $2.94 Million - $5.28 Million	-745,300 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$5.45 - $8.65 $7.97 Million - $12.7 Million	-1,462,900 Reduced 66.25%	745,300 $4.47 Million
Q3 2020 Nov 13, 2020	SELL	$4.34 - $11.43 $5.02 Million - $13.2 Million	-1,157,800 Reduced 34.4%	2,208,200 $16.4 Million
Q2 2020 Aug 13, 2020	BUY	$1.85 - $5.29 $330,813 - $945,947	178,818 Added 5.61%	3,366,000 $13.5 Million
Q1 2020 May 14, 2020	BUY	$1.24 - $4.35 $494,861 - $1.74 Million	399,082 Added 14.31%	3,187,182 $8.1 Million
Q4 2019 Feb 13, 2020	BUY	$2.3 - $5.12 $98,301 - $218,828	42,740 Added 1.56%	2,788,100 $9.7 Million
Q3 2019 Nov 13, 2019	BUY	$4.63 - $12.15 $1.03 Million - $2.7 Million	222,560 Added 8.82%	2,745,360 $12.7 Million
Q2 2019 Aug 12, 2019	BUY	$11.49 - $14.17 $4.23 Million - $5.21 Million	367,718 Added 17.06%	2,522,800 $31.1 Million
Q1 2019 May 14, 2019	BUY	$8.47 - $14.36 $7.74 Million - $13.1 Million	914,200 Added 73.67%	2,155,082 $28.6 Million
Q4 2018 Feb 13, 2019	BUY	$7.18 - $8.83 $8.91 Million - $11 Million	1,240,882 New	1,240,882 $10.7 Million

Others Institutions Holding LAB

# of Institutions

143

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $126M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account